- Home
- BOTJ vs BMEA Comparison
BOTJ vs BMEA Comparison
Compare BOTJ & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- BMEA
- Stock Information
- Founded
- BOTJ 1998
- BMEA 2017
- Country
- BOTJ United States
- BMEA United States
- Employees
- BOTJ N/A
- BMEA 63
- Industry
- BOTJ Major Banks
- BMEA Biotechnology: Pharmaceutical Preparations
- Sector
- BOTJ Finance
- BMEA Health Care
- Exchange
- BOTJ Nasdaq
- BMEA Nasdaq
- Market Cap
- BOTJ 62.0M
- BMEA 103.5M
- IPO Year
- BOTJ N/A
- BMEA 2021
- Fundamental
- Price
- BOTJ $14.25
- BMEA $1.72
- Analyst Decision
- BOTJ
- BMEA Strong Buy
- Analyst Count
- BOTJ 0
- BMEA 10
- Target Price
- BOTJ N/A
- BMEA $17.70
- AVG Volume (30 Days)
- BOTJ 3.1K
- BMEA 742.7K
- Earning Date
- BOTJ 08-04-2025
- BMEA 08-05-2025
- Dividend Yield
- BOTJ 2.86%
- BMEA N/A
- EPS Growth
- BOTJ N/A
- BMEA N/A
- EPS
- BOTJ 1.57
- BMEA N/A
- Revenue
- BOTJ $46,531,000.00
- BMEA N/A
- Revenue This Year
- BOTJ N/A
- BMEA N/A
- Revenue Next Year
- BOTJ N/A
- BMEA N/A
- P/E Ratio
- BOTJ $8.88
- BMEA N/A
- Revenue Growth
- BOTJ 7.18
- BMEA N/A
- 52 Week Low
- BOTJ $11.56
- BMEA $1.29
- 52 Week High
- BOTJ $17.05
- BMEA $13.07
- Technical
- Relative Strength Index (RSI)
- BOTJ 59.45
- BMEA 51.08
- Support Level
- BOTJ $13.75
- BMEA $1.51
- Resistance Level
- BOTJ $14.30
- BMEA $1.74
- Average True Range (ATR)
- BOTJ 0.22
- BMEA 0.09
- MACD
- BOTJ 0.05
- BMEA 0.02
- Stochastic Oscillator
- BOTJ 89.69
- BMEA 89.70
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.